Search

everythinglearnresearchcommunity

for

Search:↓

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Some common medications can harm male fertility, but many effects can be reversed.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Multiple treatments work best for hair loss.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Androgens play a key role in causing PCOS (Polycystic Ovary Syndrome).

Women with high androgen levels may have more severe COVID-19 symptoms.

Low prolactin in young women may increase heart and metabolism risks.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Minoxidil can reduce functions related to androgen receptors.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.